Nuclear factor-kappa B, involved in inflammation, host immune response, cell adhesion,
growth signals, cell proliferation, cell differentiation, and apoptosis defense, is a dimeric …

Perivascular inflammation is a prominent pathologic feature in most animal models of
pulmonary hypertension (PH) as well as in pulmonary arterial hypertension (PAH) patients …

Pulmonary arterial hypertension (PAH) is a severe cardiopulmonary dysfunctional disease,
characterized by progressive vascular remodeling. Inflammation is an increasingly …

Hypoxic pulmonary hypertension (PH) comprises a heterogeneous group of diseases
sharing the common feature of chronic hypoxia-induced pulmonary vascular remodeling …

Pulmonary hypertension (PH) is a progressive disease that arises from multiple etiologies
and ultimately leads to right heart failure as the predominant cause of morbidity and …

Inflammation is widely distributed in patients with Duchenne muscular dystrophy and
ultimately leads to progressive deterioration of muscle function with chronic muscle damage …

Pulmonary arterial hypertension is a chronic, progressive disorder of the pulmonary
vasculature with associated pulmonary and cardiac remodeling. PAH was a uniformly fatal …

Pulmonary arterial hypertension (PAH) is characterized by remodelling of pulmonary
arteries caused by a proliferation/apoptosis imbalance within the vascular wall. This …

Idiopathic pulmonary arterial hypertension (IPAH) is an incurable condition leading to right
ventricular failure and death and inflammation is postulated to be associated with vascular …

Abnormal wound healing by pulmonary artery smooth muscle cells (PASMCs) promotes
vascular remodeling in hypoxia-induced pulmonary hypertension (HPH). Increasing …